At Juniper, we make that switch seamless and fully supported so you can protect your progress without paying more than you need to
NICE guidance (NG28) recommends GLP-1 receptor agonists like Trulicity as a treatment option for adults with type 2 diabetes when: Triple therapy is required (in combination with metformin and another oral drug) The patient has a BMI 35 kg/m (or lower thresholds for some ethnic groups) with specific psychological or medical problems associated with obesity Insulin therapy would have significant occupational implications or weight loss would benefit other obesity-related comorbidities Importantly, NICE recommends continuing GLP-1 receptor agonist treatment only if the patient has had a beneficial metabolic response (a reduction of at least 11 mmol/mol [1.0%] in HbA1c and weight loss of at least 3% of initial body weight) after 6 months
PubMedPMC 18
In normal redox balance and low B 6 status, Se-GSH-Px was lower with organic selenium than with inorganic selenium, but both sources of selenium gave equivalent Se-GSH-Px responses when the diet was supplemented with vitamin B 6 (Figure 6)
Contraceptive methods that are not taken by mouth, such as the intrauterine device (coil), contraceptive implant, contraceptive injection, contraceptive patch and vaginal ring, are not affected by this specific interaction because they do not rely on absorption through the digestive system in the same way
Liquid preparations are unsuitable for reliable long-term storage
